Anthropic has acquired the AI BioTech startup Coefficient Bio for approximately $400 million. The small team, consisting of fewer than 10 members, was developing AI-driven platforms for drug research and development. This acquisition supports Anthropic’s expanding focus on life sciences, particularly through its Claude for Life Sciences initiative, which integrates AI models into biomedical research tasks. The move reflects a broader trend in the pharmaceutical industry, as companies increasingly adopt AI to enhance drug development and regulatory processes.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.pymnts.com/acquisitions/2026/anthropic-targets-biotech-growth-with-400-million-coefficient-bio-buy/
